Collecting samples and data to improve ovarian cancer early detection and prevention
Collects samples and data from people at high risk of, or with, ovarian cancer.
Key facts
- Who runs it
- Northwestern University
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- Status
- Recruiting
- People taking part
- 6,000 people, planned
- Started
- Mar 2000
- Expected to end
- Dec 2040
- Type of study
- Observational, 3 groups
- Treatments tested
- Ca-125
- screening questionnaire administration
- Surgery
- Record updated
- 28 February 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women who are at higher risk of ovarian cancer, or who are having gynecologic surgery. Specimens and data are collected to study early detection and prevention.
- Age
- 18 to 80 years
- Sex
- Women only
- Disease stage
- Either higher risk of ovarian cancer, or surgery for a gynecologic condition: a reproductive cancer, a benign gynecologic condition, a highly suspicious adnexal mass, or risk-reducing removal of the ovaries.
- Biomarker or test result
- Higher risk can mean a relative with ovarian, primary peritoneal, fallopian tube or pancreatic cancer who tested positive for a hereditary cancer syndrome such as BRCA1/2 or Lynch Syndrome.
The registry criteria, word for word
Show all 3 criteriaShow less
Other criteria
- DISEASE CHARACTERISTICS:
- Meets one of the following criteria:; Considered to be at increased risk for developing ovarian cancer, as defined by one of the following:; Has at least one first-degree relative (mother, sister, or daughter) with ovarian, primary peritoneal, or fallopian tube cancer; Has at least two first or second degree relatives diagnosed before age 50 with either ovarian, primary peritoneal, fallopian tube, and/or pancreatic cancer who have tested positive for hereditary cancer syndrome that includes an increased risk of gynecologic cancer (e.g., BRCA1/2 or Lynch Syndrome)or have increased risk as deemed by a certified genetic counselor; A personal or family history of a hereditary cancer syndrome that includes an increased risk of gynecologic cancer; Increased risk as deemed by a certified genetic counselor; Undergoing surgery for a gynecologic condition, including any of the following:; Diagnosis of a reproductive cancer; Benign gynecological condition (e.g., uterine leiomyomata, endometriosis, pelvic inflammatory disease, or follicular or corpus luteum ovarian cysts); Highly suspicious adnexal mass; Risk-reducing prophylactic oophorectomy; PATIENT CHARACTERISTICS:; Age
- Between the ages of 18 and 80
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern UniversityChicago, United StatesContact: Clinical Trials Office - Robert H. Lurie Comprehensive CancerTaking people
About the trial
What the trial wants to find out
RATIONALE: To improve strategies for detection and prevention of early-stage disease.
Read full original descriptionShow less
PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.
The 3 groups in the trial
- High Risk for Ovarian Cancer
Women who are at increased risk of ovarian cancer based on family or personal medical history who are participating in the Northwestern Ovarian Cancer Early Detection and Prevention Program clinic.
Treatment: Ca-125, screening questionnaire administration, and Surgery
- Suspected or diagnosed gynecological condition
Women who are planning to undergo surgery for their gynecological condition
- Control Group
Healthy subjects with no history of cancer and at general risk.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Northwestern Ovarian Cancer Early Detection & Prevention Program: A Specimen and Data Study
- Plain-language title
- Collecting samples and data to improve ovarian cancer early detection and preventionGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT00005095, who can take part
- Record updated
- 28 February 2025